Shares of Cipla dropped 3.55 percent, trading at Rs 1,450 on the BSE on Tuesday as investors await the company’s Q2 FY25 results scheduled for release today, October 29, 2024. Analysts expect muted growth in Cipla’s topline and bottomline, with challenges in US and domestic formulations potentially weighing on margins. Revenue and earnings outlook Zee […]
Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood. Citing IQVIA sales data, Glenmark said Vytorin tablets’ market achieved annual sales of approximately USD 92.4 million for the 12-month period ended April 2019. Image source: […]
Shares of Cipla surged more than 6 per cent in morning trade on Friday to hit a fresh 52-week high amid the buzz over one of largest global private equity funds, Blackstone, eyeing to acquire promoter stakes in the pharma company. Cipla shares reached its all-time high of Rs 1238.55 in trade on Thursday. However, […]
